[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].

Journal article

OBJECTIVE: To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals. METHODS: Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities. RESULTS: Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%. CONCLUSION: Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.

Authors: Zhang, D; Ge, L; Li, J; Li, X; Feng, F

• Journal: Zhonghua xin xue guan bing za zhi
• Volume: 39
• Issue: 5
• Pages: 397-401
• Publication date: 2011-05-01
• ISSN: 0253-3758
• Language: Chinese
• Keywords: Middle Aged; China; Secondary Prevention; Arteriosclerosis; Male; Cardiovascular Diseases; HPS2-THRIVE Collaborative Group; Aged; Hospitals; Female; Cerebrovascular Disorders; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Drug Utilization; Humans